US Broker Ratings

Rhythm Pharmaceuticals, Inc. (RYTM) Investor Outlook: 22% Upside Potential and Strong Buy Ratings

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing attention in the biotech sector with its promising pipeline focused on rare neuroendocrine diseases. As a commercial-stage biopharmaceutical company, Rhythm Pharmaceuticals is strategically..

Option Care Health, Inc. (OPCH) Stock Analysis: A Strong Buy with 37.51% Potential Upside

Option Care Health, Inc. (NASDAQ: OPCH), a leader in home and alternate site infusion services, has captured investor attention with its significant growth potential and robust analyst ratings. Based in..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Exploring a 44.50% Potential Upside in RNA Therapeutics

Avidity Biosciences, Inc. (NASDAQ: RNA) is at the forefront of a promising frontier in the biotechnology sector, leveraging innovative RNA therapeutics to address previously untreatable diseases. Headquartered in San Diego,..

Inspire Medical Systems (INSP): Analyst Consensus Points to 83.85% Potential Upside in Medical Device Innovator

Inspire Medical Systems, Inc. (NASDAQ: INSP) is capturing investor attention with its innovative approach to treating obstructive sleep apnea (OSA). The company, headquartered in Golden Valley, Minnesota, has carved a..

Universal Health Services, Inc. (UHS) Stock Analysis: A Deep Dive into Growth Potential and Analyst Ratings

Universal Health Services, Inc. (NYSE: UHS) stands as a formidable player in the healthcare sector, specifically within the Medical Care Facilities industry. Headquartered in King of Prussia, Pennsylvania, UHS operates..

Baxter International Inc. (BAX) Stock Analysis: Navigating a 23.92% Potential Upside Amidst Healthcare Sector Dynamics

Baxter International Inc. (NYSE: BAX) remains a focal point for investors seeking opportunities within the healthcare sector, particularly in the medical instruments and supplies industry. With a market capitalization of..

CVS Health Corporation (CVS) Stock Analysis: Unlocking a 22.62% Potential Upside in Healthcare

CVS Health Corporation (NYSE: CVS), a dominant player in the healthcare sector, has been a focal point for investors seeking both value and growth. With a market capitalization of $83.13..

Ionis Pharmaceuticals, Inc. (IONS) Stock Analysis: Unveiling a 39.75% Potential Upside in RNA-targeted Medicine

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), a leader in RNA-targeted therapies, has captured investor attention with its robust product portfolio and a compelling potential upside of 39.75%. As a commercial-stage biotechnology..

RadNet, Inc. (RDNT) Growth Potential: Analyst Ratings Signal 34% Upside

For investors seeking opportunities in the healthcare sector, RadNet, Inc. (NASDAQ: RDNT) presents a compelling case. As a prominent player in the diagnostics and research industry, RadNet operates a robust..

Medpace Holdings, Inc. (MEDP) Stock Analysis: Evaluating a Healthcare Giant with a Strong Return on Equity

Medpace Holdings, Inc. (NASDAQ: MEDP) stands as a titan in the healthcare sector, specializing in diagnostics and research. Founded in 1992 and headquartered in Cincinnati, Ohio, Medpace provides clinical research-driven..

ADMA Biologics Inc (ADMA): Analyzing Its 75.91% Potential Upside for Investors

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology sector, offers a compelling investment opportunity with a notable potential upside of 75.91%. As a company specializing in the..

Revolution Medicines (RVMD): An Investor’s Insight into a 105.71% Potential Upside in Precision Oncology

Revolution Medicines, Inc. (NASDAQ: RVMD) is making waves in the biotechnology sector, particularly in the field of precision oncology. With a market cap of $6.54 billion, this clinical-stage company is..

Guardant Health (GH) Stock Analysis: A Promising Opportunity with 12.99% Upside Potential

Guardant Health, Inc. (NASDAQ: GH), a leading player in the precision oncology sector, is capturing investor attention with its innovative diagnostic solutions and an attractive upside potential of 12.99%. As..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a Potential 22% Upside for Investors

Koninklijke Philips N.V. (NYSE: PHG), a titan in the healthcare sector, specifically in medical devices, commands significant investor attention with its current market cap of $25.51 billion. As a Netherlands-based..

DexCom, Inc. (DXCM) Investor Outlook: 29% Potential Upside with Strong Buy Ratings

DexCom, Inc. (NASDAQ: DXCM) is a prominent player in the healthcare sector, specifically within the medical devices industry, focusing on continuous glucose monitoring (CGM) systems. Headquartered in San Diego, California,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Exploring a 20.99% Upside Potential

Merit Medical Systems, Inc. (NASDAQ: MMSI) is capturing the attention of investors with its substantial potential upside of 20.99%, according to analyst ratings. This Utah-based company, specializing in medical instruments..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: Exploring a 64% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) presents an intriguing opportunity for investors seeking exposure in the healthcare sector, specifically within the biotechnology industry. Headquartered in Dublin, Ireland, this company is recognized..

Integer Holdings Corporation (ITGR) Stock Analysis: Exploring a 32.34% Upside Potential

Integer Holdings Corporation (NYSE: ITGR) presents an intriguing opportunity for investors keen on the healthcare sector, specifically within the medical device industry. With a substantial market capitalization of $3.73 billion,..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unpacking a 26% Upside Potential

For investors with a keen eye on the healthcare sector, Prestige Consumer Healthcare Inc. (NYSE: PBH) presents an intriguing opportunity. Known for its robust portfolio of over-the-counter health and personal..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating a -27% Potential Downside amid Revenue Growth

Oscar Health, Inc. (OSCR), a prominent player in the healthcare technology sector, presents a complex investment profile that demands careful scrutiny from individual investors. Headquartered in New York, Oscar Health..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds